Dr. Fehniger, along with Alice Zhou (Division of Oncology), George Ansstas (Division of Oncology), and Ryan Fields (Department of Medicine) have received a $1.5 million grant to support a phase 1 trial of immunotherapy for melanoma. The study will treat patients with melanoma with natural killer cell-based therapy developed at Washington University for treatment of patients with leukemia and lymphoma.
Fehniger Receives Grant from Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance
View Content